tiprankstipranks
Inari Medical to replace Callon Petroleum in S&P 600 at open on 4/1
PremiumThe FlyInari Medical to replace Callon Petroleum in S&P 600 at open on 4/1
1M ago
AppFolio to replace Inari Medical in S&P 400 at open on 4/1
PremiumThe Fly
AppFolio to replace Inari Medical in S&P 400 at open on 4/1
1M ago
Inari Medical price target lowered to $52 from $61 at Truist
PremiumThe Fly
Inari Medical price target lowered to $52 from $61 at Truist
1M ago
Piper Sandler downgrades Inari Medical to Neutral on core concerns, DOJ probe
PremiumThe FlyPiper Sandler downgrades Inari Medical to Neutral on core concerns, DOJ probe
2M ago
Inari Medical downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Inari Medical downgraded to Neutral from Overweight at Piper Sandler
2M ago
Inari Medical sees FY24 revenue $580M-$595M, consensus $588.3M
PremiumThe Fly
Inari Medical sees FY24 revenue $580M-$595M, consensus $588.3M
2M ago
Inari Medical sees FY24 revenue $580M-$595M, consensus $583.07M
PremiumThe FlyInari Medical sees FY24 revenue $580M-$595M, consensus $583.07M
4M ago
Inari Medical sees 2023 revenue at least $493.5M, consensus $491.37M
PremiumThe Fly
Inari Medical sees 2023 revenue at least $493.5M, consensus $491.37M
4M ago
Inari Medical sees Q4 revenue at least $132M, consensus $130.98M
PremiumThe Fly
Inari Medical sees Q4 revenue at least $132M, consensus $130.98M
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100